Tr1X
The Director, Clinical Operations provides strategic leadership and operational oversight for the implementation and execution of clinical trials from study start-up through close-out. This role leads cross-functional clinical study teams, directs CROs and vendors, and ensures all clinical trial activities align with corporate objectives, regulatory requirements, and quality standards. The position is responsible for mentoring and supervising clinical operations personnel while driving operational excellence and inspection readiness.
Tr1X is a clinical-stage biotechnology company engineering a novel class of regulatory T cell-based therapies to cure autoimmune and inflammatory diseases. Leveraging cutting-edge genetic engineering and deep immunology expertise, Tr1X develops allogeneic, off-the-shelf Tr1/Treg cell therapies designed to restore immune tolerance and reset the immune system. The company has four active clinical programs spanning Crohn's disease, multiple sclerosis, graft-versus-host disease prevention following stem cell transplant, and autoimmune uveitis.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tr1X.